Article info
PDFReview
Switching among branded and generic medication products during ongoing treatment of psychiatric illness
- Correspondence to Dr Jeffrey Habert, University of Toronto, Toronto, ON M5S, Canada; jhabert{at}rogers.com
Citation
Switching among branded and generic medication products during ongoing treatment of psychiatric illness
Publication history
- Received June 27, 2019
- Revised September 11, 2019
- Accepted December 13, 2019
- First published January 10, 2020.
Online issue publication
March 12, 2020
Article Versions
- Previous version (12 March 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.